Professor Feng Wu

University of Oxford

Professor Feng WU (MD & PhD) began his research career in high intensity focused ultrasound (HIFU) therapy in 1988, and developed his own clinical prototype HIFU device in China, with his work largely dedicated to treating patients with solid tumours, including those of the liver, kidney, breast, pancreas, uterus, bone, and soft tissues. In 2002, he was invited to help establish the first clinical HIFU Unit in the United Kingdom, and to assist in running clinical trials for the HIFU treatment of patients with solid malignancies in Churchill Hospital, Oxford University Hospitals. He is currently working as Honorary HIFU Consultant at Oxford University Hospitals, and also serving as Senior Clinical Scientist at Nuffield Department of Surgical Sciences, University of Oxford. He has published more than 200 papers in peer-reviewed journals, and received the William and Francis Fry Award in 2013 for his outstanding contributions to the field.

dont miss

Focused Ultrasound Therapy for Tumours: Current Status and Future Prospective

As a non-invasive procedure, focused ultrasound therapy has been increasingly used for treating patients with solid tumours. It employs focused ultrasound beam to treat a targeted tumour at depth without any damage to surrounding tissues. This presentation reviews focused ultrasound therapy with respect to its emerging clinical applications and future prospective. It also introduces an up-to-date clinical status in Oxford, ranging from tumour thermal ablation to targeted drug delivery.